In all three types of cholangiocarcinoma, Tregs, a dominant CD4+ T cell subtype, are strongly associated with poorer prognosis (DCC: p  = 0.027; HC: p = 0.001; ICC: p = 0.017) (Fig. 2). The gene discussed is CD4; the disease is cholangiocarcinoma.